Ashwagandha vs Maca Root for Perimenopause Energy and Libido: Side-by-Side Evidence Review
Maca is non-hormonal and libido-focused, ashwagandha works through cortisol and stamina. A side-by-side look at the perimenopause evidence for each.
Maca is non-hormonal and libido-focused, ashwagandha works through cortisol and stamina. A side-by-side look at the perimenopause evidence for each.
Ashwagandha stacks sensibly with magnesium, vitamin D and L-theanine, and poorly with other sedatives. What the evidence supports combining.
St John’s wort has strong mood evidence and severe drug interactions, ashwagandha has neither. How the two compare for perimenopausal mood support.
Stress and sleep changes usually appear first, at 2 to 4 weeks. A realistic timeline for what ashwagandha does and when, for midlife symptoms.
Ashwagandha’s strongest sleep data covers onset latency and sleep quality rather than total duration. What that means for perimenopausal insomnia.
The recent ashwagandha literature is small, mostly short, and rarely perimenopause-specific. What the newest trials add, and what the gaps still are.
Sustained use raises different questions from a 12-week trial. What is known about ashwagandha over months rather than weeks, in midlife and perimenopause.
A small trial reported improved sexual function scores in women on standardised ashwagandha extract. What it measured, and how much weight it can carry.
Ashwagandha shows GABA-mimetic activity in preclinical work, which may explain the calming effect. What that mechanism does and does not prove in humans.
Ashwagandha’s fertility research is largely in men, and perimenopausal fertility is a different question entirely. What the evidence actually covers.
Perimenopause symptom relief in ashwagandha trials clusters around 300 to 600 mg of standardised extract. How to find your level without chasing the maximum.
Pregnancy, hyperthyroidism, autoimmune disease, liver conditions and upcoming surgery all change the calculus. Who should not take ashwagandha, and why.